Diabetes Mellitus, Hyperglycemia, Hemoglobin A1C and the Risk of Prosthetic Joint Infections in Total Hip and Knee Arthroplasty

This publication has 42 references indexed in Scilit:

• Hemoglobin A1C as a Marker for Surgical Risk in Diabetic Patients Undergoing Total Joint Arthroplasty
  The Journal of Arthroplasty, 2013
• Importance of Perioperative Glycemic Control in General Surgery
  Annals of Surgery, 2013
• The Role of Pre-Operative and Post-Operative Glucose Control in Surgical-Site Infections and Mortality
  PLOS ONE, 2012
• The Mayo Prosthetic Joint Infection Risk Score: Implication for Surgical Site Infection Reporting and Risk Stratification
  Infection Control & Hospital Epidemiology, 2012
• Diabetes Mellitus, Hemoglobin A1C, and the Incidence of Total Joint Arthroplasty Infection
  The Journal of Arthroplasty, 2012
• Glycemic Control and Infections in Patients with Diabetes Undergoing Noncardiac Surgery
  Annals of Surgery, 2011
• Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery
  Diabetes Care, 2010
• Future Young Patient Demand for Primary and Revision Joint Replacement: National Projections from 2010 to 2030
  Clinical Orthopaedics and Related Research, 2009
• American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
  Diabetes Care, 2009
• Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery
  Circulation, 2008